Work

Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Japan (P8-12.006)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000210351

Authors: Yasuhiko Matsumori, Koichi Ikeda, Masako Kudo, Tomofumi Ishikawa, Yuko Hoshino, Hiroki Yoshimatsu, Alexandra Thiry, Akio Arakawa, Robert Croop, Terence Fullerton, Fumihiko Sakai, Takao Takeshima

Institutions: Iwate Medical University, Pfizer (Japan), Pfizer (United States), Biohaven Pharmaceuticals (United States), Saitama Neuropsychiatric Institute, Tominaga hospital

Language: English

Topic: Migraine and Headache Studies

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409227755

FWCI:

Cites:

Cited by:

Related to: 10